PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06:  MARKET SEGMENTATION BY TYPE Market segmentation by type Comparison by type Inactivated vaccines - Market size and forecast 2018-2023 Recombinant vaccines - Market size and forecast 2018-2023 Live attenuated vaccines - Market size and forecast 2018-2023 Market opportunity by type PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 North America - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Novel vaccine technology Strong investments from BRICS in research Growing inbound travel to Asia PART 12: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Bharat Biotech Ltd. Biological E. Ltd. Green Cross Corp. Sanofi Valneva SE PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO Exhibit 01: Product overview Exhibit 02: Global pharmaceuticals market Exhibit 03: Segments of global pharmaceuticals market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Type - Market share 2018-2023 (%) Exhibit 19: Comparison by type Exhibit 20: Inactivated vaccines - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Inactivated vaccines - Year-over-year growth 2019-2023 (%) Exhibit 22: Recombinant vaccines - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Recombinant vaccines - Year-over-year growth 2019-2023 (%) Exhibit 24: Live attenuated vaccines - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Live attenuated vaccines - Year-over-year growth 2019-2023 (%) Exhibit 26: Market opportunity by type Exhibit 27: Customer landscape Exhibit 28: Market share by geography 2018-2023 (%) Exhibit 29: Geographic comparison Exhibit 30: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Asia - Year-over-year growth 2019-2023 (%) Exhibit 32: Top 3 countries in Asia Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 34: ROW - Year-over-year growth 2019-2023 (%) Exhibit 35: Top 3 countries in ROW Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 37: Europe - Year-over-year growth 2019-2023 (%) Exhibit 38: Top 3 countries in Europe Exhibit 39: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 40: North America - Year-over-year growth 2019-2023 (%) Exhibit 41: Top 3 countries in North America Exhibit 42: Key leading countries Exhibit 43: Market opportunity Exhibit 44: Impact of drivers and challenges Exhibit 45: Vendor landscape Exhibit 46: Landscape disruption Exhibit 47: Vendors covered Exhibit 48: Vendor classification Exhibit 49: Market positioning of vendors Exhibit 50: Bharat Biotech Ltd. - Vendor overview Exhibit 51: Bharat Biotech Ltd. - Business segments Exhibit 52: Bharat Biotech Ltd. - Organizational developments Exhibit 53: Bharat Biotech Ltd. - Key offerings Exhibit 54: Bharat Biotech Ltd. - Key customers Exhibit 55: Biological E. Ltd. - Vendor overview Exhibit 56: Biological E. Ltd. - Business segments Exhibit 57: Biological E. Ltd. - Organizational developments Exhibit 58: Biological E. Ltd. - Key offerings Exhibit 59: Biological E. Ltd. - Key customers Exhibit 60: Green Cross Corp. - Vendor overview Exhibit 61: Green Cross Corp. - Business segments Exhibit 62: Green Cross Corp. - Organizational developments Exhibit 63: Green Cross Corp. - Geographic focus Exhibit 64: Green Cross Corp. - Segment focus Exhibit 65: Green Cross Corp. - Key offerings Exhibit 66: Green Cross Corp. - Key customers Exhibit 67: Sanofi - Vendor overview Exhibit 68: Sanofi - Business segments Exhibit 69: Sanofi - Organizational developments Exhibit 70: Sanofi - Geographic focus Exhibit 71: Sanofi - Segment focus Exhibit 72: Sanofi - Key offerings Exhibit 73: Sanofi - Key customers Exhibit 74: Valneva SE - Vendor overview Exhibit 75: Valneva SE - Business segments Exhibit 76: Valneva SE - Organizational developments Exhibit 77: Valneva SE - Geographic focus Exhibit 78: Valneva SE - Segment focus Exhibit 79: Valneva SE - Key offerings Exhibit 80: Valneva SE - Key customers Exhibit 81: Validation techniques employed for market sizing Exhibit 82: Definition of market positioning of vendors

Bharat Biotech Ltd. Biological E. Ltd. Green Cross Corp. Sanofi Valneva SE.